Methods for modulating hematopoiesis and vascular growth
CA 2280736 C · Owner: Belaoussoff, Maria · Inventors: Baron, Margaret H.; Farrington, Sarah M.; Belaoussoff, Maria
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and assays are provided for selecting compounds that are functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue for use in modulating hematopoiesis and vascular growth such compound being , exemplified by a hedgehog protein and an agonist of a hedgehog protein , binding receptor. According to the method such compound causes , undifferentiated mesodermally derived cells to undergo at least one of hematopoiesis or vasculogenesis. Examples of undifferentiated mesodermally derived cells include hematopoietic stem cells and embryonic explant cells. The method of the invention may be utilized to treat a variety of pathological conditions including …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 10, 1998 and granted May 29, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 10, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 10, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.